Home › Alzheimer's Disease › Tennessee
Alzheimer's Disease clinical trials in Tennessee
16 studies for Alzheimer's Disease are looking for participants at sites in Tennessee.
Cities in Tennessee
Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
- K2 Medical Research, Nashville
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 28, 2026 · NCT07794670A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Neurology Clinic, P.C., Cordova
RecruitingPhase 4
Ages 50 and older · All sexes · Updated Sep 25, 2026 · NCT07633470A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Vanderbilt Psychiatric Hospital, Nashville
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Sep 22, 2026 · NCT06585787Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Genesis Neuroscience Clinic, Knoxville
- K2 Medical Research - Nashville, Nashville
RecruitingPhase 3
Ages 50 to 90 · All sexes · Updated Sep 21, 2026 · NCT07177352Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- K2 Medical Research Nashville LLC, Nashville
RecruitingPhase 2
Ages 55 to 80 · All sexes · Updated Sep 21, 2026 · NCT06847321A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Neurology Clinic - Cordova /ID# 277790, Cordova
RecruitingPhase 1/2
Ages 50 to 90 · All sexes · Updated Sep 18, 2026 · NCT07599670Alzheimer's Tau Platform: Master Protocol
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 50 to 80 · All sexes · Updated Sep 8, 2026 · NCT06957418Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0031, Chattanooga
- Neurology Clinic, P.C., Cordova
- Vanderbilt University Medical Center- Village, Nashville
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 1, 2026 · NCT06808984A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Neurology Clinic, P.C., Cordova
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Aug 20, 2026 · NCT06976216A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Neurology Clinical, P.C., Cordova
RecruitingPhase 1/2
Ages 35 to 85 · All sexes · Updated Jul 10, 2026 · NCT05462106Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- Vanderbilt University Medical Center Clinical Research Center, Nashville
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Jun 22, 2026 · NCT05231798Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville
RecruitingObservational study
Ages 25 to 55 · All sexes · Updated May 18, 2026 · NCT04165109Swallowing Impairments in Adults With and Without Alzheimer's Disease
- Vanderbilt University Medical Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
Ages 60 and older · All sexes · Updated May 8, 2026 · NCT06678100Tennessee Alzheimer's Project
- Vanderbilt University Medical Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Feb 5, 2026 · NCT05372172Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
- Cumberland Medical Center, Crossville
- Roane Medical Center, Harriman
- Fort Sanders Regional Medical Center, Knoxville
- and 3 more
Recruiting
Ages 60 to 90 · All sexes · Updated Oct 29, 2025 · NCT07222280Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- National HealthCare Corporation, Murfreesboro
Recruiting
Ages 50 and older · All sexes · Updated Mar 12, 2024 · NCT05820919From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.